Spinal Cord Injury will soon get a quick fix treatment
by Celle CellA
US based company has initiated the World’s first neural stem cell trial for
spinal cord injury. The proprietary, HuCNS-SC(R) human neural stem cells is
imitated by Stem Cells Inc. in an effort to revolutionize treatment for the
most critical condition. As of now, the
company has started enrolling patients who are in stage - 3 to 12 months post
their injury and are leading in complete and (or) incomplete paralysis stage. The
clinical trial has launched and being executed at Balgrist University Hospital,
University of Zurich, Switzerland. The center is a renowned and one of the most
accredited medical centers for spinal cord injury and rehabilitation. The
scientists believe that it will unleash a new phase in stem cell treatment. As stem cells are found in cord
blood and menstrual blood, it will also lead to popularity of menstrual blood
storage and cord blood banking. People from around the world are coming to
blood bank to preserve menstrual blood.
According
to Dr. Armin Curt, MD, Professor and Chairman, Spinal Cord Injury Center at the
University Of Zurich, Switzerland, “the trial is a landmark in the field of spinal
cord injury research. The neural stem cell transplantation may be a new hope to
the patients who are facing a lot of troubles due to their paralytic
condition”. “Apart from our major focus on assessing safety, the
design of the trial will afford a very real near-term opportunity to observe
possible benefits to the patient, which may include improved sensation, motor
function, bowel or bladder function,” Dr. Curt added further.
The
first neural stem cell transplantation trial begin after the research published
in the journal Cell Transplantation, that stated that stem cells taken from umbilical cord blood cells and menstrual blood cells could
be used to treat the brain injury seen in neurodegenerative disorders.
Sponsor Ads
Created on Dec 31st 1969 18:00. Viewed 0 times.